New combo therapy aims to jumpstart immune system against stubborn melanoma

This study tested a combination of treatments for patients with advanced melanoma that had stopped responding to standard immunotherapy. The approach involved giving patients a personalized vaccine made from their own immune cells, plus three drugs designed to help those cells find and attack the cancer. The goal was to see if this combination could shrink tumors in patients who had run out of other options, but the trial was stopped early after enrolling only one participant.